Simvastatin for Treating Erectile Dysfunction (STED)
This is a randomized clinical trial, double-blind, placebo controlled, to verify if simvastatin can improve erectile dysfunction in men with endothelial dysfunction, without any cardiac disease.It is hypothesized that the simvastatin can improve the endothelial function, improving the nitric oxide liberation in corpora cavernosa of the penis, resulting in improvement of erection.
Vascular Disease Detected
C Reactive Protein
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Primary Purpose: Treatment
|Official Title:||The Effect of Simvastatin in the Penile Erection: a Randomized, Double-blind Clinical Trial|
- Penile erection [ Designated as safety issue: No ]
|Study Start Date:||January 2006|
|Study Completion Date:||December 2008|
|Primary Completion Date:||July 2008 (Final data collection date for primary outcome measure)|
|Placebo Comparator: placebo||Drug: Placebo|
simvastatin 20 daily for six months.
No Contacts or Locations Provided